NANOG induction promoted drug resistance in the breast cancer cell line MCF-7, and tumor regeneration and resistance to androgens starvation in the prostate cancer cell lines Du145 and LNCaP [22]. This evidence concerns the gene NANOG and prostate carcinoma.